<DOC>
	<DOCNO>NCT02018809</DOCNO>
	<brief_summary>To assess effectiveness report statin adherence pattern Medication Adherence Partner ( MAP ) improve outcome statin adherence versus usual care measure electronic pill bottle . Hypothesis : Subjects MAP receive daily adherence feedback high statin adherence arm , measure pill bottle data .</brief_summary>
	<brief_title>Social Forces Improve Statin Adherence ( Study A )</brief_title>
	<detailed_description>We propose complete randomize control trial ( RCT ) 200 subject medication treat diabetes evidence poor adherence statin medication ( &lt; 70 % medication possession ratio determine pharmacy record ; combination med ) . Study subject use electronic pill bottle ( GlowCap ) store statin medication . Study subject identify potential Medication Adherence Partners ( MAPs ) receive information adherence pattern enrollment . For 90-day trial , subject randomize : 1 ) subject 's MAP receive daily notification whether subject take statin ; 2 ) subject 's MAP receive weekly often subject take statin previous week ; 3 ) subject 's MAP receive notification subject miss &gt; 2 consecutive daily dos statin ; 4 ) usual care ( GlowCaps without notification ) . The primary outcome percent statin dose take study measure GlowCaps . The secondary outcome subject ' statin medication possession ratio ( MPR ) study .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>The subject Humana insure The subject English speaking adult Age range ≥18 year The subject diagnosis diabetes ≥12 month The subject MPR &lt; 70 % statin medication Subject deny sideeffects statin medication The subject identify person agree serve MAP The subject &lt; 18 year old The subject consider part vulnerable population ( prisoner , cognitively impaired person , pregnant woman ) On statin combination medication The subject identify individual agrees serve MAP The subject report clinically important side effect statin medication active liver disease :</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Medication Adherence</keyword>
	<keyword>High Blood Pressure</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Statins</keyword>
</DOC>